(AGN) Aegon - AS
Sector: Financial Services | Industry: Insurance - Diversified | Exchange: AS (Netherlands) | Market Cap: 11.420m EUR | Total Return: 32% in 12m
Avg Turnover: 38.4M
Qual. Beats: 0
Rev. Trend: -21.9%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality
Aegon Ltd. (ticker: AGN), listed on the Amsterdam stock exchange (AS), is a large-cap Dutch financial services group operating in the insurance and retirement space across the Americas, the Netherlands, the United Kingdom, and other international markets. The company was founded in 1844 and is headquartered in Schiphol, the Netherlands.
Its product portfolio spans retirement plans, mutual funds, unit-linked products, annuities, and life and health insurance, with distribution concentrated under the Transamerica brand (notably in the United States) and the World Financial Group brand. Aegon is classified under the GICS Multi-line Insurance sub-industry, reflecting its mix of life insurance, retirement, and asset management offerings rather than a focus on property and casualty lines.
As a multi-line insurance provider, Aegons business model is built on collecting premiums and retirement contributions, managing long-duration investment portfolios, and generating fee-based income from asset management activities. The companys geographic and product diversification is typical of European insurance groups that have expanded into the US retirement market.
- Higher US rates lift Transamerica net investment income margins
- Variable annuity hedge gains reduce earnings volatility and capital strain
- Capital returns accelerate via buybacks and dividends after US asset sales
- UK and Dutch pension reforms drive fee-based retirement inflows
| Net Income: 976.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA -0.12 > 1.0 |
| NWC/Revenue: 80.64% < 20% (prev 117.9%; Δ -37.24% < -1%) |
| CFO/TA 0.00 > 3% & CFO 928.0m > Net Income 976.0m |
| Net Debt (2.60b) to EBITDA (1.11b): 2.35 < 3 |
| Current Ratio: error (cannot be calculated; needs correct Total Current Assets and Liabilities) |
| Outstanding Shares: last quarter (1.51b) vs 12m ago -9.57% < -2% |
| Gross Margin: 17.82% > 18% (prev 14.80%; Δ 3.02% > 0.5%) |
| Asset Turnover: 8.00% > 50% (prev 5.96%; Δ 2.04% > 0%) |
| Interest Coverage Ratio: 3.79 > 6 (EBIT TTM 1.28b / Interest Expense TTM 337.0m) |
| A: 0.07 (Total Current Assets 20.8b - Total Current Liabilities 0.0) / Total Assets 317b |
| B: 0.01 (Retained Earnings 4.23b / Total Assets 317b) |
| C: 0.00 (EBIT TTM 1.28b / Avg Total Assets 322b) |
| D: 0.02 (Book Value of Equity 7.53b / Total Liabilities 310b) |
| Altman-Z'' = 0.53 = B |
| DSRI: 3.0 (Receivables 17.6b/3.83b, Revenue 25.8b/19.5b) |
| GMI: 0.83 (GM 14.80% / 17.82%) |
| AQI: 1.03 (AQ_t 0.93 / AQ_t-1 0.91) |
| SGI: 1.32 (Revenue 25.8b / 19.5b) |
| TATA: 0.00 (NI 976.0m - CFO 928.0m) / TA 317b) |
| Beneish M = -1.29 (Cap -4..+1) = D |
As of June 28, 2026, the stock is trading at EUR 7.45 with a total of 3,301,709 shares traded. Over the past week, the price has changed by +0.08%, over one month by +1.57%, over three months by +25.27% and over the past year by +31.99%.
Current recommended Stop Loss: 7.20 (which is 3.4% or 2.1 ATR below the current price).
Aegon has no consensus analysts rating.
P/E Trailing = 12.5833
P/E Forward = 10.0
P/S = 0.9366
P/B = 1.2136
P/EG = 14.2828
Revenue TTM = 25.8b EUR
EBIT TTM = 1.28b EUR
EBITDA TTM = 1.11b EUR
Long Term Debt = 3.53b EUR (from longTermDebt, last quarter)
Short Term Debt = 41.0m EUR (from shortTermDebt, last quarter)
Debt = 5.79b EUR (from shortLongTermDebtTotal, last quarter) + Leases 187.0m
Net Debt = 2.60b EUR (calculated: Debt 5.79b - CCE 3.19b)
Enterprise Value = 14.0b EUR (11.4b + Debt 5.79b - CCE 3.19b)
Interest Coverage Ratio = 3.79 (Ebit TTM 1.28b / Interest Expense TTM 337.0m)
EV/FCF = -26.56x (Enterprise Value 14.0b / FCF TTM -528.0m)
FCF Yield = -3.76% (FCF TTM -528.0m / Enterprise Value 14.0b)
FCF Margin = -2.05% (FCF TTM -528.0m / Revenue TTM 25.8b)
Net Margin = 3.78% (Net Income TTM 976.0m / Revenue TTM 25.8b)
Gross Margin = 17.82% ((Revenue TTM 25.8b - Cost of Revenue TTM 21.2b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 0.04 (Enterprise Value 14.0b / Total Assets 317b)
Interest Expense / Debt = 5.82% (Interest Expense 337.0m / Debt 5.79b)
Taxrate = 6.32% (66.0m / 1.04b)
NOPAT = 1.20b (EBIT 1.28b * (1 - 6.32%))
Current Ratio = unknown (Total Current Assets 20.8b / Total Current Liabilities 0.0)
Debt / Equity = 0.77 (Debt 5.79b / totalStockholderEquity, last quarter 7.53b)
Debt / EBITDA = 2.35 (Net Debt 2.60b / EBITDA 1.11b)
Debt / FCF = -4.93 (negative FCF - burning cash) (Net Debt 2.60b / FCF TTM -528.0m)
Total Stockholder Equity = 8.62b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.30% (Net Income 976.0m / Total Assets 317b)
RoE = 11.33% (Net Income TTM 976.0m / Total Stockholder Equity 8.62b)
RoCE = 10.51% (EBIT 1.28b / Capital Employed (Equity 8.62b + L.T.Debt 3.53b))
RoIC = 0.41% (EBIT 1.28b / (Assets 317b - Curr.Liab 0.0 - Cash 3.19b))
WACC = 7.79% (E(11.4b)/V(17.2b) * Re(8.97%) + D(5.79b)/V(17.2b) * Rd(5.82%) * (1-Tc(0.06)))
Discount Rate = 8.97% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -61.38 | Cagr: -11.18%
[DCF] Fair Price = unknown (Cash Flow -528.0m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.0 | # QB: 0
Revenue Correlation: -21.90 | Revenue CAGR: -4.64% | SUE: 1.54 | # QB: 1
EPS current Year (2026-12-31): EPS=0.90 | Chg30d=+1.12% | Revisions=N/A | GrowthEPS=+9.9% | GrowthRev=+1.1%
EPS next Year (2027-12-31): EPS=0.94 | Chg30d=-0.53% | Revisions=-20% | GrowthEPS=+4.8% | GrowthRev=+2.1%
[Analyst] Revisions Ratio: -20%